Skip to main content

News

By Tammy Lovell | 12:20 pm | September 04, 2020
The AnapnoGuard solution has been introduced by several Israeli hospitals in order to reduce complications caused by ventilators.     
By Ahmed El Sherif | 09:29 am | September 04, 2020
A joint venture between the UAE’s Mubadala Development Company and Switzerland’s Medgate AG, the centre was assessed on its quality of coding, collection and submission of clinical data, including during the COVID-19 pandemic.
By Tammy Lovell | 08:23 am | September 04, 2020
The COVID-19 pandemic has accelerated telehealth development in countries around the world, including Italy. In this on-demand session at the HIMSS & Health 2.0 European Digital Conference, Italian healthcare experts reflect on the progress made in digital health. 
By Kat Jercich | 06:33 pm | September 03, 2020
The SF-based health tech company says its telemedicine platform saw double-digit growth during the pandemic.
By Kat Jercich | 06:29 pm | September 03, 2020
A George Mason University professor argues in a new report that hurdles to entrepreneurial exploration are slowing telehealth expansion.  
By MobiHealthNews | 03:59 pm | September 03, 2020
Also: Viz.ai landed a New Technology Add-on Payment designation from CMS, and a Canadian company rolls out new return-to-work wearable. 
By Dave Muoio | 03:08 pm | September 03, 2020
Although beyond the reach of everyday users, an independent study lends support to the Apple Watch's ECG as an option for cardiologists when standard ECGs are unavailable.
By Laura Lovett | 02:27 pm | September 03, 2020
A new consumer report from Accenture found that rates of smartphone-app and wearable use have slightly declined over the last two years. 
By Mallory Hackett | 01:20 pm | September 03, 2020
The pediatrics care delivery space has long been operating with a gap in innovative health solutions.
By Dave Muoio | 11:48 am | September 03, 2020
Biofourmis has restructured its business to pursue its original focus on data-driven patient monitoring alongside its more recent interest in standalone and companion digital therapeutics.